An Introduction to Rare Movement Disorders

An Introduction to Rare Movement Disorders

Buenos Aires, Argentina – August 16-17, 2019

An Introduction to Rare Movement Disorders will be held August 16-17, 2019 in Buenos Aires, Argentina.Course Directors

Emilia Gatto, MD, FAAN – INEBA – Sanatorio Trinidad Mitre; Buenos Aires, Argentina
Martin Emiliano Cesarini, MD – INEBA – IPENSA; La Plata, Argentina

Course Description
  • Join us and learn how to identify rare movement disorders, its rational approach and how to recognize treatable rare movement disorders
  • Acquire information on the selection criteria for appropriate genetic studies, how to refer patients to specialized centers and explore new diagnosis and treatment tools (genetics techniques, clinical approach, orphan drugs, innovative technologies)
  • Discuss the social aspects on rare disorders, in relation to organizations, management, etc.
  • Course topics will focus on new genetic technologies, hypokinetic and hyperkinetic rare disorders; neuro-metabolics, ataxias disorders and social aspects of rare disorders with movement disorders
  • The course allows for networking with the experts and peers
     
Language of the Course

The course will be presented in Spanish with some talks presented in English, noted with an asterisk in the program. Translation services will not be available. One of the strategic goals for MDS-Pan American Section is to introduce English lectures gradually to courses where English is not the primary language.

Video Challenge

Participants are encouraged to submit a short patient video case presentation for the Video Challenge session to be held on Saturday, August 17 at 15:30-16:30. The goal of this session is for participants to learn from a series of unusual and interesting patient cases and to see how senior experts approach these types of challenging cases. Presenters are required to have patient consent, if patient is featured in the video or who are otherwise identifiable.

Video Challenge Instructions

Format Requirements and Guidelines (presentation can be in English or in Spanish, if accepted)

  • Use of the provided Power Point template is required for submission
         - Video Case Template 2019 Rare Disease BA.pptx
  • Presentations should be no more than 8 minutes in length and must have a known diagnosis that is explained at the end of the presentation. The diagnosis should not be part of the title. The goal is not to share the diagnosis with the audience, until the end of the presentation
  • Introduction slide, for reviewers:
         - Title of case
         - Brief statement of why the case is unique or of interest
         - What is the known diagnosis
  • One title slide: title of case (do not use the diagnosis in the title of the case), your full name/institution/ city/ state/country
  • History/brief summary of case: two slides maximum 
  • Video clip: up to three minutes in duration
  • Audience discussion of: Phenomenology, differential diagnosis and investigations
  • Presentation of the known diagnosis, and relevant review of the condition: three slides maximum
     

Submission (Do not email presentations)

  • Use the Dropbox link to submit your presentation, with embedded videos
  • File name: Your last name, first name
  • Incomplete or late presentations will not be considered
     

Review Process

The course directors will review and select from the submitted cases which cases will be presented on Saturday for the Video Challenge. Those selected to present a case will be judged by faculty and the best case presentation will be selected.

Competition

Although the main aim of this exercise is educational, we have applied to MDS for a grant to enable the author of the top presentation to receive a complimentary registration to attend the 3rd PAS Congress, to be held in Miami, FL, USA, February 14-16, 2020. 

Patient Consent

The author(s) of the Work hereby represents and confirms that he/she has obtained the written consent of any and all patient(s) featured or who are otherwise identifiable or used in the Work to such feature, identification or other use therein and that said consent fully complies with all applicable legal requirements relating to the use of said such patient identifiable material, including, without limitation, if applicable, the specific requirements of the United States Health Insurance Portability and Accountability Act of 1996 ("HIPAA")…

Important Dates to Note:

  • July 18, 2019: Submit a patient video case for consideration - deadline
  • August 6, 2019: Notification status emailed
  • August 17, 2019: Pre-selected cases will be presented by the attendees and a panel of experts will compete to make a correct diagnosis
  • Incomplete or late submissions will not be accepted
     
Recommended Audience

This course is directed toward Movement Disorder specialists, general neurologists and trainees, clinical geneticists, biologists, allied health professionals, ONG organizations and pharmaceutical companies' research, development and innovative teams.

Learning Objectives 
  • Recognize rare movement disorders related to rare diseases
  • Identify the variability of phenotype-genotype, and according with these findings, provide rational potential new therapeutic pathways
  • Describe specific available treatments for rare movement disorders
  • Identify new innovative technologies for rare movement disorders management and their effects on specific symptoms
  • Explain the role of the neurologists in the identification and management of patients with rare movement disorders
     
Venue

Neuroscience Institute of Buenos Aires – INEBA
Guardia Vieja 4435 
Ciudad Autónoma de Buenos Aires, Argentina

Visa Statement

MDS is able to provide participants with a Letter of Support and any course-related documentation needed to assist in obtaining a visa. Please note that MDS is unable to contact the Embassy on your behalf. It is the responsibility of each participant to make the necessary arrangements related to this process. However, if the official who is handling your application needs further clarification, please have them contact education@movementdisorders.org.

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice